Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events

被引:28
作者
D'Erasmo, Laura [1 ]
Minicocci, Ilenia [1 ]
Di Costanzo, Alessia [1 ]
Pigna, Giovanni [1 ]
Commodari, Daniela [1 ]
Ceci, Fabrizio [2 ]
Montali, Anna [1 ]
Brancato, Francesca [1 ]
Stanca, Ilaria [1 ]
Nicolucci, Antonio [3 ]
Ascione, Andrea [4 ]
Galea, Nicola [4 ]
Carbone, Iacopo [5 ]
Francone, Marco [4 ]
Maranghi, Marianna [1 ]
Arca, Marcello [1 ]
机构
[1] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy
[2] Sapienza Univ Rome, Dept Expt Med, Rome, Italy
[3] Ctr Outcomes Res & Clin Epidemiol, CORESEARCH, Pescara, Italy
[4] Sapienza Univ Rome, Dept Radiol Sci Oncol & Pathol, Rome, Italy
[5] Sapienza Univ Rome, ICOT Hosp, Dept Radiol Sci Oncol & Pathol, Latina, Italy
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2021年 / 10卷 / 09期
关键词
atherosclerosis; cardiovascular disease; genetics; hypercholesterolemia; therapy; FAMILIAL HYPERCHOLESTEROLEMIA; DISEASE; MUTATIONS; SOCIETY; SCORE;
D O I
10.1161/JAHA.120.018932
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Familial hypercholesterolemia (FH) may arise from deleterious monogenic variants in FH-causing genes as well as from a polygenic cause. We evaluated the relationships between monogenic FH and polygenic hypercholesterolemia in influencing the long-term response to therapy and the risk of atherosclerosis. Methods and Results A cohort of 370 patients with clinically diagnosed FH were screened for monogenic mutations and a low-density lipoprotein-rising genetic risk score >0.69 to identify polygenic cause. Medical records were reviewed to estimate the response to lipid-lowering therapies and the occurrence of major atherosclerotic cardiovascular events during a median follow-up of 31.0 months. A subgroup of patients (n=119) also underwent coronary computed tomographic angiography for the evaluation of coronary artery calcium score and severity of coronary stenosis as compared with 135 controls. Two hundred nine (56.5%) patients with hypercholesterolemia were classified as monogenic (FH/M+), 89 (24.1%) as polygenic, and 72 (19.5%) genetically undefined (FH/M-). The response to lipid-lowering therapy was poorest in monogenic, whereas it was comparable in patients with polygenic hypercholesterolemia and genetically undetermined. Mean coronary artery calcium score and the prevalence of coronary artery calcium >100 units were significantly higher in FH/M+ as compared with both FH/M- and controls. Finally, after adjustments for confounders, we observed a 5-fold higher risk of incident major atherosclerotic cardiovascular events in FH/M+ (hazard ratio, 4.8; 95% CI, 1.06-21.36; P-adj=0.041). Conclusions Monogenic cause of FH is associated with lower response to conventional cholesterol-lowering therapies as well as with increased burden of coronary atherosclerosis and risk of atherosclerotic-related events. Genetic testing for hypercholesterolemia is helpful in providing important prognostic information.
引用
收藏
页数:22
相关论文
共 32 条
[1]   QUANTIFICATION OF CORONARY-ARTERY CALCIUM USING ULTRAFAST COMPUTED-TOMOGRAPHY [J].
AGATSTON, AS ;
JANOWITZ, WR ;
HILDNER, FJ ;
ZUSMER, NR ;
VIAMONTE, M ;
DETRANO, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (04) :827-832
[2]   Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) [J].
Averna, Maurizio ;
Cefalu, Angelo B. ;
Casula, Manuela ;
Noto, Davide ;
Arca, Marcello ;
Bertolini, Stefano ;
Calandra, Sebastiano ;
Catapano, Alberico L. ;
Tarugi, Patrizia .
ATHEROSCLEROSIS SUPPLEMENTS, 2017, 29 :11-16
[3]   Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study [J].
Casula, Manuela ;
Olmastroni, Elena ;
Pirillo, Angela ;
Catapano, Alberico Luigi .
ATHEROSCLEROSIS, 2018, 277 :413-418
[4]   Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis [J].
Chora, Joana Rita ;
Medeiros, Ana Margarida ;
Alves, Ana Catarina ;
Bourbon, Mafalda .
GENETICS IN MEDICINE, 2018, 20 (06) :591-598
[5]   CAD-RADS™ Coronary Artery Disease - Reporting and Data System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology [J].
Cury, Ricardo C. ;
Abbara, Suhny ;
Achenbach, Stephan ;
Agatston, Arthur ;
Berman, Daniel S. ;
Budoff, Matthew J. ;
Dill, Karin E. ;
Jacobs, Jill E. ;
Maroules, Christopher D. ;
Rubin, Geoffrey D. ;
Rybicki, Frank J. ;
Schoepf, U. Joseph ;
Shaw, Leslee J. ;
Stillman, Arthur E. ;
White, Charles S. ;
Woodard, Pamela K. ;
Leipsic, Jonathon A. .
JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY, 2016, 10 (04) :269-281
[6]   Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: A retrospective, single center, observational study [J].
D'Erasmo, Laura ;
Commodari, Daniela ;
Di Costanzo, Alessia ;
Minicocci, Ilenia ;
Polito, Luca ;
Ceci, Fabrizio ;
Montali, Anna ;
Maranghi, Marianna ;
Arca, Marcello .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2020, 30 (11) :2027-2035
[7]   Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes [J].
D'Erasmo, Laura ;
Di Costanzo, Alessia ;
Cassandra, Francesca ;
Minicocci, Ilenia ;
Polito, Luca ;
Montali, Anna ;
Ceci, Fabrizio ;
Arca, Marcello .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (12) :2531-2541
[8]   Autosomal Recessive Hypercholesterolemia Long-Term Cardiovascular Outcomes [J].
D'Erasmo, Laura ;
Minicocci, Ilenia ;
Nicolucci, Antonio ;
Pintus, Paolo ;
Van Lennep, Janine E. Roeters ;
Masana, Luis ;
Mata, Pedro ;
Maria Sanchez-Hernandez, Rosa ;
Prieto-Matos, Pablo ;
Real, Jose T. ;
Ascaso, Juan F. ;
Esteve Lafuente, Eduardo ;
Pocovi, Miguel ;
Fuentes, Francisco J. ;
Muntoni, Sandro ;
Bertolini, Stefano ;
Sirtori, Cesare ;
Calabresi, Laura ;
Pavanello, Chiara ;
Averna, Maurizio ;
Cefalu, Angelo Baldassare ;
Noto, Davide ;
Pacifico, Adolfo Arturo ;
Pes, Giovanni Mario ;
Harada-Shiba, Mariko ;
Manzato, Enzo ;
Zambon, Sabina ;
Zambon, Alberto ;
Vogt, Anja ;
Scardapane, Marco ;
Sjouke, Barbara ;
Fellin, Renato ;
Arca, Marcello .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (03) :279-288
[9]   Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy [J].
Di Costanzo, Alessia ;
Belardinilli, Francesca ;
Bailetti, Diego ;
Sponziello, Marialuisa ;
D'Erasmo, Laura ;
Polimeni, Licia ;
Baratta, Francesco ;
Pastori, Daniele ;
Ceci, Fabrizio ;
Montali, Anna ;
Girelli, Gabriella ;
De Masi, Bruna ;
Angeloni, Antonio ;
Giannini, Giuseppe ;
Del Ben, Maria ;
Angelico, Francesco ;
Arca, Marcello .
SCIENTIFIC REPORTS, 2018, 8
[10]   Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage [J].
Di Costanzo, Alessia ;
D'Erasmo, Laura ;
Polimeni, Licia ;
Baratta, Francesco ;
Coletta, Paola ;
Di Martino, Michele ;
Loffredo, Lorenzo ;
Perri, Ludovica ;
Ceci, Fabrizio ;
Montali, Anna ;
Girelli, Gabriella ;
De Masi, Bruna ;
Angeloni, Antonio ;
Catalano, Carlo ;
Maranghi, Marianna ;
Del Ben, Maria ;
Angelico, Francesco ;
Arca, Marcello .
ATHEROSCLEROSIS, 2017, 257 :232-239